DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S., released its 2024 Sustainability Report, “A World Worth Seeing.” The report focuses on the company’s performance across its Social, Employees,…
Category: News
GLP-1 Users May Face Optic Nerve Damage Risk in First Year
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity. Medscape Medical News
National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, has awarded $7,000 in scholarships to three optometry students whose passion for community impact and…
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Ophthalmology and Therapy has published results from a phase 3 stu…
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
CAMBRIDGE, England–(BUSINESS WIRE)–Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical trial for its lea…
betterview Reaches 20,000 Eyes Treated in Four Years
WINTERTHUR, Switzerland–(BUSINESS WIRE)–betterview, a Swiss provider of refractive eye surgery, has announced that it has reached the milestone of 20,000 eyes treated since its founding in 2021. Since its launch, the company has built a network of te…
betterview verzeichnet 20'000 behandelte Augen in vier Jahren
WINTERTHUR, Schweiz–(BUSINESS WIRE)–betterview, ein Anbieter für refraktive Chirurgie in der Schweiz, gibt bekannt, dass das Unternehmen die Marke von 20’000 behandelten Augen erreicht hat. Der Meilenstein wurde seit der Gründung des Unternehmens im …
Veligrotug Shows Promise for Treating Thyroid Eye Disease
The THRIVE and THRIVE-2 clinical trials showed significant improvements in proptosis and diplopia in active as well as chronic thyroid eye disease, earning FDA Breakthrough Therapy designation. Medscape Medical News
Can Medicare Afford the Perpetual Human?
As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer and healthier life. Medscape Medical News
Continuous Use of Tear Drops Eases Dry Eye Symptoms in AMD
Continuous use of eye drops in patients with neovascular AMD who receive frequent eye injections soothes dry eye more effectively than intermittent use, a new study shows. Medscape Medical News
NIH Launches Agency-Wide Plan for Autoimmune Research
The 5-year strategy aims to accelerate diagnosis, prevention, and treatment for the millions living with autoimmune diseases in the US. Medscape Medical News
Experts Warn of Hidden Psychological Burden in Glaucoma
Anxiety and depression are more common among people with glaucoma than in the general population but often go unrecognized, highlighting the need for routine psychometric screening in this population, a new study finds. Medscape Medical News
Identifying, Referring Cataracts in Primary Care
Cataracts can happen at any age, but risk is heightened in older adults and people with diabetes. Medscape Medical News
Affirm et Groupe Vision New Look s’associent pour offrir des options de paiement flexibles dans les principales lunetteries au Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ : AFRM), le réseau de paiement qui aide les consommateurs à acheter ce qu’ils souhaitenten toute liberté et soutient la croissance des marchands, et Groupe Vision New Look, un chef de file nord-américain des mag…
Affirm and New Look Vision Group partner to offer flexible payment options across leading eyewear retailers in Canada
TORONTO–(BUSINESS WIRE)–Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, and New Look Vision Group, a leading North American optical retailer with over 475 stores in the US and Canada, today announc…
Myopic Macular Degeneration Market Analysis and Forecast Report 2025-2035 with Regeneron Pharmaceuticals, F. Hoffmann-La Roche, and Bayer Leading Innovations – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myopic Macular Degeneration Market – A Global and Regional Analysis: Focus on Regional and Country Analysis – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global myopic …
Sleep Apnea Can Raise Risk for Retinal Vein Disease
A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is associated with worse outcomes in patients who already have the condition. Medscape Medical News
Cloudbreak Pharma Inc. Announces Positive Phase 2 Results for CBT-004 in Patients with Vascularized Pinguecula
IRVINE, Calif.–(BUSINESS WIRE)– #clinicaltrials–Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evalu…
Study Finds Link Between IL-6 and Diabetic Eye Disease
A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be predictive of disease progression. Medscape Medical News
Ora Appoints Industry Veteran Bill Sharbaugh as Chairman of the Board of Directors
BOSTON–(BUSINESS WIRE)– #ClinicalResearch–Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.